The significance of the can be that although antibiotic resistant Chlamydia hasn’t been seen in patients, it can occur in the laboratory. If resistance did take place in the overall population, it would not really end up being detected by current diagnostic techniques. Related StoriesCrucial change in single DNA base predisposes children to aggressive form of cancerNew study uncovers antibiotic prescription styles across EnglandCancer DNA in patient's bloodstream may help deliver personalized treatment for liver malignancy’Until now a person treated with antibiotics with a reoccurring illness of C. Trachomatis was assumed to have been re-contaminated’ says Dr Nicholas Thomson, senior author from the Wellcome Trust Sanger Institute. ‘The current gaps in our understanding of the population make-up of Chlamydia limit our ability to implement health plans, because we don’t realize how Chlamydia spreads within our population fully.’ This study is not just important for the treating the sexually transmitted strains of Chlamydia but also for the treatment of African Chlamydia strains that can trigger infectious blindness, or trachoma.The NHS was discovered to have 17,157 extra deaths in 2004 weighed against France, Germany, the Netherlands and Spain. The TaxPayers’ Alliance, a combined group which is campaigning for lower taxes, looked at mortality amenable to health care i.e. The number of deaths from particular conditions and at specific ages that health care can reasonably be likely to avert. According to the survey, if that difference between your UK figure and the common was used to the whole population, it would mean 17,157 deaths, five times the number that die in road accidents.